NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at the 2010 Morgan Stanley Global Healthcare Unplugged Conference on Monday, September 13, 2010, in New York. Elliott Sigal, executive vice president, chief scientific officer and president, Research & Development, will make a presentation about the company at 8:35 a.m. EDT.
Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. An archived edition of the presentation will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Professional Services Banking Finance Communications Public Relations/Investor Relations General Health